| Literature DB >> 35891953 |
Abstract
Background: One of the deadliest and most prevalent cancer is pancreatic ductal adenocarcinoma (PDAC). Microarray has become an important tool in the research of PDAC genes and target therapeutic drugs.Entities:
Keywords: Biomarker; Co-expression; Differentially expressed genes; Endoplasmic reticulum; Gene ontology pathway enrichment; Pancreatic ductal adenocarcinoma
Year: 2022 PMID: 35891953 PMCID: PMC9284245 DOI: 10.30498/ijb.2021.292558.3092
Source DB: PubMed Journal: Iran J Biotechnol ISSN: 1728-3043 Impact factor: 1.266
Summary of the PDAC data sets.
| GEO data set | Samples | Expressed Probes |
|---|---|---|
| GSE78229 | 50 PDAC tumor tissue | 33,297 probes on Affymetrix Human Gene 1.0 ST Array |
| GSE62452 | 61 adjacent non-tumor tissue | 33,297 probes on Affymetrix Human Gene 1.0 ST Array |
Figure 1The raw GSE62452 and GSE78229 microarray datasets subject to quality control to examine high-dimensional structure of datasets using UMAP.
Figure 2A) The boxplot explains the gene expression values of samples of the original datasets without normalization. B) Plots displaying the expression difference in PDAC tumor and normal tissues. Black illustrates no change (NO), red illustrates low-expressed (Down), and blue represents over-expressed (Up) DEGs, FC, fold change.
Figure 3A) Ascertainment of soft-thresholding power and the examination of the scale-free fit index for several soft-thresholding powers. B) Dendrogram of the differentially expressed genes. The DEGs are clustered based on a dissimilarity measure (1- TOM) highly clustered in the turquoise module. C) Distribution of mean gene significance and errors in the modules linked with the PDAC traits. D) Heatmap of the correlation between module eigengenes and the tumor and normal samples (traits) of the PDAC.
Gene expression dataset retrieved with top significant pathways GO annotations analysis of the turquoise module in PDAC
| Category | Term | Count | % | Pvalue | Genes |
|---|---|---|---|---|---|
| GO_BP_FAT | GO:0000904~cell morphogenesis involved in differentiation | 12 | 13.33 | 4.89E-05 | RAB10, BMPR2, USP9X, KIF5B, SLITRK5, DNAJB1, CENPE, CTNNA2, MT3, ANTXR1, SPTBN1, CORO1C |
| GO_BP_FAT | GO:0007409~axonogenesis | 9 | 10 | 8.67E-05 | RAB10, BMPR2, USP9X, KIF5B, SLITRK5, CENPE, CTNNA2, MT3, SPTBN1 |
| GO_BP_FAT | GO:0016192~vesicle-mediated transport | 16 | 17.78 | 1.34E-04 | CDC42SE1, HSPA4, RALB, COG6, EIF2AK1, MSN, SNX31, HSP90B1, CORO1C, JCHAIN, RAB10, MYO1B, GOLPH3, KIF5B, B2M, SPTBN1 |
| GO_BP_FAT | GO:0061564~axon development | 9 | 10 | 1.45E-04 | RAB10, BMPR2, USP9X, KIF5B, SLITRK5, CENPE, CTNNA2, MT3, SPTBN1 |
| GO_BP_FAT | GO:0000902~cell morphogenesis | 14 | 15.56 | 2.72E-04 | CDC42SE1, BMPR2, USP9X, MSN, DNAJB1, CENPE, ANTXR1, MT3, CORO1C, RAB10, KIF5B, SLITRK5, CTNNA2, SPTBN1 |
| GO_BP_FAT | GO:0048667~cell morphogenesis involved in neuron differentiation | 9 | 10 | 3.03E-04 | RAB10, BMPR2, USP9X, KIF5B, SLITRK5, CENPE, CTNNA2, MT3, SPTBN1 |
| GO_BP_FAT | GO:0008104~protein localization | 20 | 22.22 | 4.20E-04 | PDIA6, HSPA4, RALB, COG6, NCOA4, MSN, SNX31, MT3, UBAC2, HSP90B1, CORO1C, RAB10, GOLPH3, KIF5B, RAB18, SLC25A5, GLUL, PAM, SPTBN1, FBN1 |
| GO_BP_FAT | GO:0031175~neuron projection development | 11 | 12.22 | 4.69E-04 | RAB10, BMPR2, USP9X, KIF5B, SLITRK5, DNAJB1, CENPE, CTNNA2, B2M, MT3, SPTBN1 |
| GO_BP_FAT | GO:0032989~cellular component morphogenesis | 14 | 15.56 | 5.02E-04 | CDC42SE1, BMPR2, USP9X, MSN, DNAJB1, CENPE, ANTXR1, MT3, CORO1C, RAB10, KIF5B, SLITRK5, CTNNA2, SPTBN1 |
| GO_BP_FAT | GO:0007155~cell adhesion | 16 | 17.78 | 5.45E-04 | PDIA6, HSPA4, MSN, DNAJB1, ANTXR1, CORO1C, RAB10, MYO1B, GOLPH3, VCAN, EIF2S3, KIF5B, CTNNA2, B2M, SPTBN1, FBN1 |
| GO_BP_FAT | GO:0000904~cell morphogenesis involved in differentiation | 12 | 13.33 | 4.89E-05 | RAB10, BMPR2, USP9X, KIF5B, SLITRK5, DNAJB1, CENPE, CTNNA2, MT3, ANTXR1, SPTBN1, CORO1C |
| GO_MF_FAT | GO:0050839~cell adhesion molecule binding | 10 | 11.11 | 2.36E-05 | RAB10, HSPA4, MYO1B, EIF2S3, KIF5B, MSN, CTNNA2, P4HB, SPTBN1, FBN1 |
| GO_MF_FAT | GO:0032403~protein complex binding | 12 | 13.33 | 4.59E-05 | HSPA4, PDIA6, PPP1CC, MYO1B, PLS3, CTNNA2, P4HB, ANTXR1, SPTBN1, CORO1C, FBN1, JCHAIN |
| GO_MF_FAT | GO:0097367~carbohydrate derivative binding | 20 | 22.22 | 8.89E-05 | HSPA4, RALB, BMPR2, MMP7, EIF2AK1, HSP90B1, JCHAIN, RAB10, MYO1B, SMCHD1, VCAN, EIF2S3, KIF5B, PDE3A, RAB18, YME1L1, GLUL, TRPM6, B2M, FBN1 |
| GO_MF_FAT | GO:0005543~phospholipid binding | 8 | 8.89 | 1.92E-04 | HSPA4, GOLPH3, MYO1B, ANXA5, PON1, ANXA2P2, SNX31, SPTBN1 |
| GO_MF_FAT | GO:0008289~lipid binding | 10 | 11.11 | 3.48E-04 | HSPA4, GOLPH3, MYO1B, FABP7, ANXA5, PON1, ANXA2P2, SNX31, CD1B, SPTBN1 |
| GO_MF_FAT | GO:0098641~cadherin binding involved in cell-cell adhesion | 7 | 7.78 | 4.50E-04 | RAB10, HSPA4, MYO1B, EIF2S3, KIF5B, CTNNA2, SPTBN1 |
| GO_MF_FAT | GO:0098632~protein binding involved in cell-cell adhesion | 7 | 7.78 | 5.48E-04 | RAB10, HSPA4, MYO1B, EIF2S3, KIF5B, CTNNA2, SPTBN1 |
| GO_MF_FAT | GO:0098631~protein binding involved in cell adhesion | 7 | 7.78 | 5.98E-04 | RAB10, HSPA4, MYO1B, EIF2S3, KIF5B, CTNNA2, SPTBN1 |
| GO_MF_FAT | GO:0045296~cadherin binding | 7 | 7.78 | 6.08E-04 | RAB10, HSPA4, MYO1B, EIF2S3, KIF5B, CTNNA2, SPTBN1 |
| GO_MF_FAT | GO:0051015~actin filament binding | 5 | 5.56 | 0.001071 | MYO1B, PLS3, CTNNA2, ANTXR1, CORO1C |
| GO_CC_FAT | GO:0070062~extracellular exosome | 30 | 33.33 | 8.98E-08 | C5ORF46, RALB, PON1, ANTXR1, N4BP2L2, HSP90B1, JCHAIN, GLUL, B2M, SPTBN1, PDIA6, HSPA4, PARP4, MMP7, ANXA5, MSN, DNAJB1, GNG12, RAB10, MYO1B, EIF2S3, SUB1, RAB18, SERINC1, P4HB, PABPC1, ANXA2P2, SLC25A5, PAM, FBN1 |
| GO_CC_FAT | GO:1903561~extracellular vesicle | 30 | 33.33 | 1.01E-07 | C5ORF46, RALB, PON1, ANTXR1, N4BP2L2, HSP90B1, JCHAIN, GLUL, B2M, SPTBN1, PDIA6, HSPA4, PARP4, MMP7, ANXA5, MSN, DNAJB1, GNG12, RAB10, MYO1B, EIF2S3, SUB1, RAB18, SERINC1, P4HB, PABPC1, ANXA2P2, SLC25A5, PAM, FBN1 |
| GO_CC_FAT | GO:0043230~extracellular organelle | 30 | 33.33 | 1.01E-07 | C5ORF46, RALB, PON1, ANTXR1, N4BP2L2, HSP90B1, JCHAIN, GLUL, B2M, SPTBN1, PDIA6, HSPA4, PARP4, MMP7, ANXA5, MSN, DNAJB1, GNG12, RAB10, MYO1B, EIF2S3, SUB1, RAB18, SERINC1, P4HB, PABPC1, ANXA2P2, SLC25A5, PAM, FBN1 |
| GO_CC_FAT | GO:0044421~extracellular region part | 35 | 38.89 | 1.63E-07 | C5ORF46, RALB, BMPR2, PON1, ANTXR1, N4BP2L2, HSP90B1, JCHAIN, GLUL, B2M, SPTBN1, PDIA6, HSPA4, CPA1, PARP4, MMP7, ANXA5, MSN, DNAJB1, CENPE, GNG12, MT3, RAB10, MYO1B, VCAN, EIF2S3, SUB1, RAB18, SERINC1, P4HB, PABPC1, ANXA2P2, SLC25A5, PAM, FBN1 |
| GO_CC_FAT | GO:0005912~adherens junction | 15 | 16.67 | 3.22E-07 | HSPA4, ANXA5, MSN, HSP90B1, CORO1C, RAB10, PPP1CC, MYO1B, EIF2S3, KIF5B, P4HB, PABPC1, CTNNA2, B2M, SPTBN1 |
| GO_CC_FAT | GO:0070161~anchoring junction | 15 | 16.67 | 4.32E-07 | HSPA4, ANXA5, MSN, HSP90B1, CORO1C, RAB10, PPP1CC, MYO1B, EIF2S3, KIF5B, P4HB, PABPC1, CTNNA2, B2M, SPTBN1 |
| GO_CC_FAT | GO:0031988~membrane-bounded vesicle | 32 | 35.56 | 1.70E-06 | C5ORF46, RALB, PON1, ANTXR1, N4BP2L2, HSP90B1, JCHAIN, KIF5B, GLUL, B2M, SPTBN1, PDIA6, HSPA4, PARP4, MMP7, ANXA5, MSN, DNAJB1, GNG12, MT3, RAB10, MYO1B, EIF2S3, SUB1, RAB18, SERINC1, P4HB, PABPC1, ANXA2P2, SLC25A5, PAM, FBN1 |
| GO_CC_FAT | GO:0005576~extracellular region | 35 | 38.89 | 1.35E-05 | C5ORF46, RALB, BMPR2, PON1, ANTXR1, N4BP2L2, HSP90B1, JCHAIN, GLUL, B2M, SPTBN1, PDIA6, HSPA4, CPA1, PARP4, MMP7, ANXA5, MSN, DNAJB1, CENPE, GNG12, MT3, RAB10, MYO1B, VCAN, EIF2S3, SUB1, RAB18, SERINC1, P4HB, PABPC1, ANXA2P2, SLC25A5, PAM, FBN1 |
| GO_CC_FAT | GO:0005925~focal adhesion | 10 | 11.11 | 1.94E-05 | RAB10, HSPA4, PPP1CC, ANXA5, MSN, P4HB, PABPC1, B2M, HSP90B1, CORO1C |
| KEGG_PATHWAY | hsa05200:Pathways in cancer | 6 | 6.67 | 0.0168 | RALB, NCOA4, DNAJB1, CTNNA2, GNG12, HSP90B1 |
| KEGG_PATHWAY | hsa04141:Protein processing in endoplasmic reticulum | 4 | 4.44 | 0.0276 | HSPA4, EIF2AK1, P4HB, HSP90B1 |
| KEGG_PATHWAY | hsa04612:Antigen processing and presentation | 3 | 3.33 | 0.0353 | HSPA4, PDIA6, B2M |
| KEGG_PATHWAY | hsa04728:Dopaminergic synapse | 3 | 3.33 | 0.0891 | PPP1CC, KIF5B, GNG12 |
| KEGG_PATHWAY | hsa05162:Measles | 3 | 3.33 | 0.0951 | HSPA4, EIF2AK1, MSN |
Figure 4The bar plot shows 30 top GO annotations regarding A) biological processes (BP), B) molecular function (MF), and C) cellular component (CC). They are represented by axes text color brown, purple, and red respectively. D) The top five KEGG pathway enrichments of the turquoise module is shown. E) The gradual color change from red to the yellow node was comparable to the degree of connectivity in the weighted gene co-expression network; positive correlation in the red, and negative correlation in the yellow nodes. Black-circled nodes present the ER protein processing pathway associated genes.
The top 15 common hub genes of PPI network of the turquoise module in PDAC tumor and non-tumor tissues gene expression data.
| Gene ID | Genes | Nodes | Betweenness centrality | Expression | Fold Cut-off |
|---|---|---|---|---|---|
| 3312 | HSPA4 | 103 | 38655.36 | 7.26105469 | 7.26 |
| 26986 | PABPC1 | 76 | 30322.54 | 5.54081207 | 5.54 |
| 7184 | HSP90B1 | 47 | 18422.09 | 6.67241036 | 6.67 |
| 5501 | PPP1CC | 45 | 26263.34 | 5.83112829 | 5.83 |
| 8239 | USP9X | 31 | 11968.88 | 4.62837378 | 4.62 |
| 1968 | EIF2S3 | 24 | 7240.32 | 5.25950649 | 5.25 |
| 4478 | MSN | 21 | 18382.39 | 5.39104874 | 5.39 |
| 10890 | RAB10 | 21 | 16158.94 | 3.86893387 | 3.86 |
| 659 | BMPR2 | 19 | 8073 | 4.48815865 | 4.48 |
| 5034 | P4HB | 18 | 7982.73 | 6.27703351 | 6.27 |
| 7316 | UBC | 17 | 61998.78 | 0 | 6.89 |
| 567 | B2M | 15 | 6307 | 6.00173613 | 6.00 |
| 292 | SLC25A5 | 15 | 5591.53 | 4.94497369 | 4.94 |
| 4316 | MMP7 | 10 | 9309 | 5.35016667 | 5.35 |
| 6711 | SPTBN1 | 10 | 3685.11 | 5.38178162 | 5.38 |
| 5899 | RALB | 10 | 3223.23 | 3.82931216 | 3.82 |
| 3337 | DNAJB1 | 10 | 3750.13 | 3.24341789 | 3.78 |
| 1062 | CENPE | 9 | 3730 | 3.35601213 | 5.10 |
| 10130 | PDIA6 | 9 | 4500 | 4.27824156 | 5.21 |
Figure 5Survival study of the real hub genes in PDAC datasets. Effect of expression levels on PDAC patients of survival. A) HSPA4 (Logrank p = 0.0034), B) DNAJB1 (Logrank p = 0.012), C) PABBC1 (Logrank p = 0.025) D) P4HB (Logrank p = 0.093), E) PDIA6 (Logrank p = 0.034), F) RAB10 (Logrank p = 0.0027), G) RALB (Logrank p = 0.017), and H) EIF2S3 (Logrank p = 0.01). Red lines and blue lines represent high expression and low expression of the real hub genes, respectively.